Nurix Therapeutics, Inc.
Ticker: 1549595
values in millions
Revenue & Profit Trend
in millionsRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q1 FY2026 | Q3 FY2025 | Q2 FY2025 | Q1 FY2025 | Q3 FY2024 | Q2 FY2024 | Q1 FY2024 | Q3 FY2023 |
|---|---|---|---|---|---|---|---|---|
| INCOME | ||||||||
| Revenue | 6.25-20.8% | 7.89-82.1% | 44.06+138.8% | 18.45+46.5% | 12.59+4.1% | 12.09-27.1% | 16.59-10.2% | 18.47 |
| Total Income | 6.25-20.8% | 7.89-82.1% | 44.06+138.8% | 18.45+46.5% | 12.59+4.1% | 12.09-27.1% | 16.59-10.2% | 18.47 |
| EXPENSES | ||||||||
| Expenditure | 98.75-0.5% | 99.28+7.5% | 92.38+13.6% | 81.32+21.0% | 67.20+10.8% | 60.63-1.9% | 61.80+5.7% | 58.48 |
| Tax | 0.00 | 0.00-100.0% | 0.76 | 0.00-100.0% | 0.08-11.1% | 0.09+0.0% | 0.09 | 0.00 |
| PROFIT | ||||||||
| PBT | — | -86.42-102.4% | -42.70+24.2% | -56.35-15.3% | -48.87-9.9% | -44.46-7.3% | -41.43 | — |
| Net Profit | -87.17-0.9% | -86.42-98.8% | -43.46+22.9% | -56.35-15.1% | -48.96-9.9% | -44.55-7.3% | -41.52-12.3% | -36.98 |
| KEY METRICS | ||||||||
| OPM % | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% |
| NPM % | -100.00% | -100.00%-1.34pp | -98.66%+1.34pp | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% |
| EPS | -0.79+23.3% | -1.03-98.1% | -0.52+22.4% | -0.67+0.0% | -0.67+5.6% | -0.71+6.6% | -0.76-11.8% | -0.68 |
Corporate Events
Board MeetingNRIX
202615May
Board Meeting
2026 Annual Meeting of Stockholders to vote on the election …
SEC Filing ↗